Check out what we’ve been up to and where can we connect!
September 21, 2021
The results from this study provide important information about the clinical management of hospitalized patients with COVID-19. Additional research is needed to identify a method that can be used to accurately prioritize patients with COVID-19 at risk of critical illness or death.
Tiziana and FHI Clinical announce collaboration on a Phase 2 study in Brazil to evaluate the safety, tolerability and efficacy of intranasal Foralumab in hospitalized patients with severe COVID-19 and pulmonary inflammation.
Results of the Adaptive COVID-19 Treatment Trial (ACTT)-2 investigating combination treatment with baricitinib, a Janus kinase inhibitor, and remdesivir for the treatment of COVID-19 in hospitalized adults were published in the New England Journal of Medicine (NEJM) on March 4, 2021, showing that the combination treatment was superior to remdesivir alone.
March 29, 2021
Phase I/II studies to evaluate human placental hematopoietic stem cell–derived natural killer (NK) cell therapy to treat COVID-19 in hospitalized adults are currently ongoing as part of our partnership with the Infectious Disease Research Institute (IDRI).
October 4-6, 2021
Attending the Maryland Life Sciences Bio Innovation Conference? Schedule some time with our team and attend the panel discussion with our Scientific Advisory Expert, Dr. Stephen Thomas.
In this webcast we will explore the intended purpose of ICH regulations; what organizations stand to gain from adopting the updated guidelines; how organizations can improve their operational efficiencies by minimizing duplicate quality-assurance steps; strategies for quick, relatively straightforward adoption of the new guidelines.
FHI Clinical is proud to support Making it Plain: the Colors of COVID Barbershop and Salon Talk including our Scientific Advisory Expert, Dr. Stephen Thomas, PhD.
April 29, 2021
Biomedical researchers, clinical research organizations, people infected and impacted by the pandemic, along with Black barbers and stylists, will come together in a virtual event April 29 at 6 p.m. to provide straight talk about fears, trust issues, and why we need our Black and Brown community to be part of COVID-19 vaccine research.
April 20-22, 2021
Attending the Global Forum on TB Vaccines? Visit our booth to learn more about our services or schedule a meeting with our team.
April 21, 2021
Join us for this panel discussion in which experts in infectious diseases will discuss the effect of WHO recommendations around TPT for individuals at high risk of TB infection and increased TPT use on TB vaccine development.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA